Cargando…

Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review

N-Acetylcysteine (NAC) is widely used in respiratory medicine, with a maximum licensed dose in chronic use of 600 mg/day; however, some clinical trials have studied the efficacy of NAC at higher doses. The aim of this review was to evaluate the adverse effects profile of NAC at higher than the stand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calverley, Peter, Rogliani, Paola, Papi, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892733/ https://www.ncbi.nlm.nih.gov/pubmed/33326056 http://dx.doi.org/10.1007/s40264-020-01026-y

Ejemplares similares

Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases
por: Mokra, Daniela, et al.
Publicado: (2023)

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
por: Cazzola, Mario, et al.
Publicado: (2015)

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)

Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study
por: Papi, Alberto, et al.
Publicado: (2020)

Efficacy and Safety of N-Acetylcysteine for Chronic Obstructive Pulmonary Disease and Chronic Bronchitis
por: Zhang, Li, et al.
Publicado: (2022)

Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation
por: Cazzola, Mario, et al.
Publicado: (2017)

A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis
por: Dauletbaev, N, et al.
Publicado: (2009)

Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine
por: Santus, Pierachille, et al.
Publicado: (2014)

The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
por: Raghu, Ganesh, et al.
Publicado: (2021)

Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
por: Tardiolo, Giuseppe, et al.
Publicado: (2018)

High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial
por: Johnson, Kara, et al.
Publicado: (2016)

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2021)

α(1)-Antitrypsin deficiency and chronic respiratory disorders
por: Cazzola, Mario, et al.
Publicado: (2020)

N-Acetylcysteine to Combat COVID-19: An Evidence Review
por: Shi, Zhongcheng, et al.
Publicado: (2020)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset
por: Calverley, Peter M A, et al.
Publicado: (2022)

Role of N-acetylcysteine in the management of COPD
por: Sadowska, Anna M, et al.
Publicado: (2006)

The role for N-acetylcysteine in the management of COPD
por: Dekhuijzen, PNR, et al.
Publicado: (2006)

Medical and Dietary Uses of N-Acetylcysteine
por: Šalamon, Špela, et al.
Publicado: (2019)

Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19
por: Izquierdo, José Luis, et al.
Publicado: (2022)

N-acetylcysteine in the Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Ansari, Sheeba F, et al.
Publicado: (2019)

Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease
por: Tse, Hoi Nam, et al.
Publicado: (2014)

N-acetylcysteine in COPD: why, how, and when?
por: Sanguinetti, Claudio M.
Publicado: (2016)

N-Acetylcysteine (NAC): Impacts on Human Health
por: Tenório, Micaely Cristina dos Santos, et al.
Publicado: (2021)

Principles behind SLE treatment with N-acetylcysteine
por: Nasr, Sandy, et al.
Publicado: (2022)

N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review
por: Jo, Sang-Ho
Publicado: (2011)

N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review
por: Guerini, Marta, et al.
Publicado: (2022)

Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine
por: de Andrade, Kívia Queiroz, et al.
Publicado: (2015)

N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2023)

Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients
por: De Backer, Jan, et al.
Publicado: (2013)

Effect of High-Dose Intravenous N-acetylcysteine on the Concentration of Plasma Sulfur-Containing Amino Acids
por: Hong, Sae-Yong, et al.
Publicado: (2005)

Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose
por: Duffull, S. B., et al.
Publicado: (2013)

Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
por: Rogliani, Paola, et al.
Publicado: (2022)

Effects of N-Acetylcysteine in Ozone-Induced Chronic Obstructive Pulmonary Disease Model
por: Li, Feng, et al.
Publicado: (2013)

Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia
por: Willborn, Robert J., et al.
Publicado: (2019)

N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence
por: Ooi, Soo Liang, et al.
Publicado: (2018)

Cough in chronic obstructive pulmonary disease: is it important and what are the effects of treatment?
por: Calverley, Peter MA
Publicado: (2013)

N-acetylcysteine in the Treatment of Trichotillomania
por: Rodrigues-Barata, Ana Rita, et al.
Publicado: (2012)

N-acetylcystein in dengue hepatitis
por: Wiwanitkit, Viroj
Publicado: (2014)

Protonation Equilibria of N-Acetylcysteine
por: Fazary, Ahmed E., et al.
Publicado: (2020)

GSH rescue by N-acetylcysteine
por: Ruffmann, R., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_jcped0ij06gl9ra7n1not5hplc